Increased serum transferrin receptor 1 levels are associated with severity of acute ischemic stroke in patients with Covid-19 pneumonia
Ideggyógyászati szemle · 2026 · 79 (5-6) · 181-188
DOI: 10.18071/isz.79.0181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ideggyógyászati szemle, 2026. Verfasst von Zülfikar Memiş und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Haseki Research and Training Hospital, Health Sciences University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: COVID-19, Receptors, Transferrin, Ischemic Stroke, Antigens, CD.
Themen: Schlaganfall
Abstract (Originalsprache)
Background and purpose – Acute ischemic stroke (AIS) is often encountered during the clinical course of coronavirus disease 2019 (COVID-19) infection. Accumulated evidence has indicated involvement of ferroptosis in AIS. Our aim was to investigate the association between serum levels of ferroptosis markers and severity of AIS in COVID-19 patients. Methods – Twenty-nine consecutively enrolled COVID-19+ pneumonia patients with AIS due to middle cerebral artery (MCA) occlusion, 25 COVID-19+ pneumonia patients without AIS and 26 AIS patients without COVID-19 infection were included. Serum levels of ferroptosis markers glutathione peroxidase 4 (GPX4), dipeptidylpeptidase-4 (DPP4) and soluble transferrin receptor 1 (sTFR1) were measured by ELISA. Results – While serum GPX4 levels were comparable among groups, COVID-19 patients with and without AIS showed significantly increased serum sTFR1 levels and COVID-19 patients with AIS showed significantly decreased serum DPP4 levels. In patients with COVID-19 and AIS, serum levels of DPP4 and sTFR1 respectively showed negative and positive correlation with levels of D-dimer and/or C-reactive protein (CRP). Levels of ferroptosis markers did not correlate with clinical/prognostic features of pneumonia or AIS. Nevertheless, COVID-19 patients with higher (≥ 131 pg/ ml) sTFR1 levels were more likely to exhibit severe pneumonia, increased clinical severity of AIS (assessed by the national institutes of health stroke and modified Rankin scales) and elevated D-dimer/CRP levels. Our results indicate TFR1 as a potential role player in both COVID-19 pneumonia and arterial thrombosis associated with COVID-19 infection. The biomarker utility of sTFR1 in these disorders should further be evaluated. Conclusion – Our results suggest that AIS associated with COVID-19 have a different pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Haseki Research and Training Hospital, Health Sciences University, Istanbul, Türkiye.
- Department of Neuroscience, Aziz Sancar Institute for Experimental Medical Research, Istanbul University, Istanbul, Türkiye.
ORCID-Profile: Zülfikar Memiş, Selen Soylu, Muhammet Duran Bayar, Aysel Büşra Şişman, Nuray Sancar, Erdem Tüzün, Birgül Baştan
Zitieren
APA
Memiş, Z., Soylu, S., Duran Bayar, M., Büşra Şişman, A., Sancar, N., Tüzün, E., & Baştan, B. (2026). Increased serum transferrin receptor 1 levels are associated with severity of acute ischemic stroke in patients with Covid-19 pneumonia. Ideggyógyászati szemle, 79(5-6), 181-188. https://doi.org/10.18071/isz.79.0181
Vancouver
Memiş Z, Soylu S, Duran Bayar M, Büşra Şişman A, Sancar N, Tüzün E, et al. Increased serum transferrin receptor 1 levels are associated with severity of acute ischemic stroke in patients with Covid-19 pneumonia. Ideggyógyászati szemle. 2026;79(5-6):181-188. doi:10.18071/isz.79.0181
BibTeX
@article{Memi2026,
author = {Memiş, Zülfikar and Soylu, Selen and Duran Bayar, Muhammet and Büşra Şişman, Aysel and Sancar, Nuray and Tüzün, Erdem and Baştan, Birgül},
title = {Increased serum transferrin receptor 1 levels are associated with severity of acute ischemic stroke in patients with Covid-19 pneumonia},
journal = {Ideggyógyászati szemle},
year = {2026},
volume = {79},
number = {5-6},
pages = {181--188},
doi = {10.18071/isz.79.0181}
}
EUVIMED